Medical & Dental

plcoskinawarded $1.7M to develop biodegradable breast implants using 3D printing technology

基于韩国的生物技术初创公司plcoskinis set to lead an international joint research project focused on developing a new type of 3D printed breast implant.

和...一起Yonsei UniversityLipoCoatPlcoskin是一家位于荷兰的医疗设备涂料公司,在未来三年内将获得约2B赢(170万美元)。资金将由Eurostar 2提供,这是一项由国际联合技术发展计划European Commission以及欧洲联合研发网络“尤里卡”的秘书处。

woo-yeol baek, CEO of Plcoskin, said, “With this joint R&D, we will further develop artificial implant manufacturing technology with LipoCoat, a leading company in lipid film coating technology in the Netherlands, and PCL-collagen coating technology based on Plcoskin’s 3D printing.”

Yonsei University campus. Photo via Yonsei University.
Yonsei University campus. Photo via Yonsei University.

乳房切除术和乳房重建

根据World Health Organization去年,全世界有230万妇女被诊断出患有乳腺癌。作为世界上女性最普遍的癌症,乳腺癌每年造成近70万人死亡。

Most breast cancer patients end up having to undergo a mastectomy, a procedure that involves either partial or full removal of the affected breast tissue. Thanks to the power of modern-day oncology, however, survival rates are greater than 90%, meaning more and more women are seeking breast reconstruction treatments to replace the lost soft tissue.

Many of these breast reconstruction surgeries involve using a soft artificial implant in the shape of a breast, but with 3D printing technology, the implants can be further personalized according to the needs of the patient.

基于PCL的可生物降解乳房植入物

自2017年成立以来,Plcoskin已完全专注于研究和开发用于再生医学应用的人工植入物,填充剂和假体。就在去年,该公司被首尔行业促销局(SBA)称为“有前途的海外生物公司”,目前正在国内批准中。该公司也在准备美国FDA和European CE MDR approval next year.

Plcoskin的最新联合研究项目旨在开发3D印刷的聚二苯二甲酸(PCL)基于PCL-胶原蛋白和脂质膜中涂有的可生物降解的乳房植入物。该公司利用Eurostar 2资金,宣布了针对海外再生医学市场的计划。

LipoCoat’s contribution to the project is the provision of a patented bio-coating technology, which is designed to improve implant infection rates while reducing post-op discomfort. On the other hand, Yonsei University’s Department of Biomedical Engineering is on board to help out with the lab-based research work.

一位公司发言人说:“我们正在与Yonsei University进行研究,以创建一个复杂的软组织,该软组织超出了现有的再生治疗限制。”

plcoskinalso has its own pharmaceutical cosmetics brand called YOULIEF, which currently offers seven different skincare products through several online and offline channels. YOULIEF’s product portfolio, which includes toners and creams, was developed in collaboration with the约翰·霍普金斯School of Medicine andMaryland Institute College of Art.

This certainly isn’t the first time additive manufacturing has been used for breast cancer treatments, beyond just 3D printed implants. Last month, 3D printer manufacturer3D系统announced a co-development agreement withCollPlant, a regenerative medicine firm, to develop3D生物打印软组织结构用于乳房重建治疗。软组织结构与乳房植入物结合起来,将用于为下乳房提供支撑并扩展植入物口袋,从而增加植入物的整体覆盖范围。

Elsewhere, researchers at北卡罗来纳州立大学以前已经使用3D打印来开发更舒适癌症患者的辐射反射天线to wear during microwave breast hyperthermia procedures. Compared to mainstream radiotherapy gear, the team’s flexible receiver is less bulky and can be printed according to the anatomy of the patient.

Nominations for the2021 3D印刷行业奖现在开放,在谁领导该行业方面发表意见。

订阅3D打印行业newsletter有关增材制造中的最新消息。雷电竞充值您也可以通过关注我们来保持联系Twitter,喜欢我们Facebook,然后调查3D打印行业YouTube频道.

寻找添加剂制造业的职业?雷电竞充值访问3D Printing Jobsfor a selection of roles in the industry.

特色图片显示Yonsei University校园。通过Yonsei University的照片。